Colon Microflora in Infants Fed Formula with Galacto- and Fructo-Oligosaccharides: More Like Breast-Fed Infants
Микрофлора толстой кишки у младенцев, получающих смесь с галакто- и фруктоолигосахаридами: большее сходство с младенцами на грудном вскармливании
2004-12-28
SCID: 54.1/hu8ba4hz
Discuss with AI
Bifidobacteriafructo-oligosaccharides (FOS)galacto-oligosaccharides (GOS)infant formulashort-chain fatty acids
Figures from the paper
Abstract (AI)
OBJECTIVES: The intestinal flora of breast-fed infants is generally dominated by Bifidobacteria. We aimed to investigate whether an infant formula supplemented with galacto-oligosaccharides and fructo-oligosaccharides (GOS/FOS) is able to establish a bifido-dominant microflora, not only in numbers but also with respect to the metabolic activity in the colon. METHODS: Two groups of infants fed infant formula with 0.8 g/100 ml GOS/FOS in a ratio of 9:1 (OSF group), or control formula (SF group) were evaluated in a randomised, double blind, placebo controlled intervention study. A breast-fed group was studied in parallel. At study onset and after 4 and 6 weeks, faecal samples were examined for the number of bifidobacteria, pH, short chain fatty acids and lactate. RESULTS: After 6 weeks, the mean proportion of bifidobacteria was significantly higher in the OSF group (59.6% versus 49.5% in the SF group; P < 0.05). Compared with controls, infants in the OSF group had a lower stool mean pH and an increased proportion of acetate and a decreased proportion of propionate. The mean pH in the OSF and SF groups were 5.7 and 6.3, respectively (P < 0.001). CONCLUSIONS: The addition of the prebiotic GOS/FOS mixture to an infant formula has a stimulating effect on the growth of bifidobacteria and on the metabolic activity of the total intestinal flora. The changes in short chain fatty acids, lactate and pH in the prebiotic group represent a fermentation profile that is closer to that observed in breast-fed infants compared to infants fed control formula.
Key Findings
1
A randomized, double-blind, placebo-controlled study evaluated formula containing 0.8 g/100 ml GOS/FOS in a 9:1 ratio versus control formula, with breast-fed infants studied in parallel.
2
After six weeks, bifidobacteria constituted 59.6% of fecal bacteria in the GOS/FOS group versus 49.5% with control formula (P < 0.05).
3
Changes in bifidobacteria, short-chain fatty acids, lactate, and pH produced a fermentation profile more similar to that of breast-fed infants.
4
GOS/FOS supplementation lowered mean stool pH to 5.7 versus 6.3 with control formula (P < 0.001).
5
The prebiotic formula increased the acetate proportion and decreased the propionate proportion compared with control formula.
Research Object
Colon microflora in infants fed GOS/FOS-supplemented or control formula
Research Subject
Effects of GOS/FOS supplementation on bifidobacterial abundance and intestinal metabolic activity, including stool pH, short-chain fatty acids, and lactate, compared with control- and breast-fed infants
Publication Details
Publication Date
2004-12-28
Journal
Publisher
ISSN
Cited by
429
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by16
Quantitative Real-Time PCR Analysis of FecalLactobacillusSpecies in Infants Receiving a Prebiotic Infant Formula2006
Quantitative Real-Time PCR Assays To Identify and Quantify Fecal Bifidobacterium Species in Infants Receiving a Prebiotic Infant Formula2005
Prebiotics in infants for prevention of allergy2013
Intestinal microbiota in infants at high risk for allergy: Effects of prebiotics and role in eczema development2017
Physiological and Bifidogenic Effects of Prebiotic Supplements in Infant Formulae2011
Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review2012
Prebiotics in infant formula2014
Fecal microbiome and metabolome of infants fed bovine MFGM supplemented formula or standard formula with breast-fed infants as reference: a randomized controlled trial2019
Bifidogenic Effects of Solid Weaning Foods With Added Prebiotic Oligosaccharides: A Randomised Controlled Clinical Trial2006
Fermented infant formula (with Bifidobacterium breve C50 and Streptococcus thermophilus O65) with prebiotic oligosaccharides is safe and modulates the gut microbiota towards a microbiota closer to that of breastfed infants2020
Partly Fermented Infant Formulae With Specific Oligosaccharides Support Adequate Infant Growth and Are Well‐Tolerated2016
A Partly Fermented Infant Formula with Postbiotics Including 3′-GL, Specific Oligosaccharides, 2′-FL, and Milk Fat Supports Adequate Growth, Is Safe and Well-Tolerated in Healthy Term Infants: A Double-Blind, Randomised, Controlled, Multi-Country Trial2020
Gastrointestinal Tolerance, Growth and Safety of a Partly Fermented Formula with Specific Prebiotics in Healthy Infants: A Double-Blind, Randomized, Controlled Trial2019
A synbiotic intervention modulates meta-omics signatures of gut redox potential and acidity in elective caesarean born infants2021
The Effect of Infant Formulas With 4 or 8 g/L GOS/FOS on Growth, Gastrointestinal Symptoms, and Behavioral Patterns: A Prospective Cohort Study2021
Early-life fecal microbiome and metabolome dynamics in response to an intervention with infant formula containing specific prebiotics and postbiotics2022